Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Two to Tango – Phosphorylation and Ubiquitination in IKK activation. Edition No. 1

VDM Publishing House, June 2009, Pages: 140


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Nuclear Factor – kappa B (NF-?B) is a major
transcription factor that controls the survival
and functioning of cells. Deregulated
NF-?B is associated with auto-immune
disorders and Cancer. NF-?B in T cells decides the
fate of an immune reaction. NF-?B is turned on by T
cell receptor (TCR) activation by a signaling
cascade that involves CARMA1-BCL10-MALT1 (CBM) and
Inhibitor of kappa B kinase (IKK) complex. TCR
inducibly phosphorylates and ubiquitinates IKK
complex to activate NF-?B. However, the molecular
mechanism of IKK complex activation and the
events that interconnect CBM and IKK
complexes are not well understood. This study
evaluates the roles and requirements of IKK
phosphorylation and ubiquitination. This study finds
that the phosphorylation of IKK is mediated by PKC-
TAK1 complex and ubiquitination is mediated by CBM
complex independently. Thus, phosphorylation and
ubiquitination of the IKK complex are controlled by
two distinct signaling pathways. This study proposes
a working model for TCR induced NF-?B activation,
which depicts that the CBM complex regulates IKK
ubiquitination, whereas PKC-TAK1 regulates IKK
phosphorylation.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds